BACKGROUND: There is evidence that exposure to passive smoking in general, and in babies in particular, is an important cause of morbimortality. Passive smoking is related to an increased risk of pediatric diseases such as sudden death syndrome, acute respiratory diseases, worsening of asthma, acute-chronic middle ear disease and slowing of lung growth.The objective of this article is to describe the BIBE study protocol. The BIBE study aims to determine the effectiveness of a brief intervention within the context of Primary Care, directed to mothers and fathers that smoke, in order to reduce the exposure of babies to passive smoking (ETS). METHODS/ DESIGN: Cluster randomized field trial (control and intervention group), multicentric and open. SUBJECT: Fathers and/or mothers who are smokers and their babies (under 18 months) that attend pediatric services in Primary Care in Catalonia.The measurements will be taken at three points in time, in each of the fathers and/or mothers who respond to a questionnaire regarding their baby's clinical background and characteristics of the baby's exposure, together with variables related to the parents' tobacco consumption. A hair sample of the baby will be taken at the beginning of the study and at six months after the initial visit (biological determination of nicotine). The intervention group will apply a brief intervention in passive smoking after specific training and the control group will apply the habitual care. DISCUSSION: Exposure to ETS is an avoidable factor related to infant morbimortality. Interventions to reduce exposure to ETS in babies are potentially beneficial for their health.The BIBE study evaluates an intervention to reduce exposure to ETS that takes advantage of pediatric visits. Interventions in the form of advice, conducted by pediatric professionals, are an excellent opportunity for prevention and protection of infants against the harmful effects of ETS. TRIAL REGISTRATION: Clinical Trials.gov Identifier: NCT00788996.
RCT Entities:
BACKGROUND: There is evidence that exposure to passive smoking in general, and in babies in particular, is an important cause of morbimortality. Passive smoking is related to an increased risk of pediatric diseases such as sudden death syndrome, acute respiratory diseases, worsening of asthma, acute-chronic middle ear disease and slowing of lung growth.The objective of this article is to describe the BIBE study protocol. The BIBE study aims to determine the effectiveness of a brief intervention within the context of Primary Care, directed to mothers and fathers that smoke, in order to reduce the exposure of babies to passive smoking (ETS). METHODS/ DESIGN: Cluster randomized field trial (control and intervention group), multicentric and open. SUBJECT: Fathers and/or mothers who are smokers and their babies (under 18 months) that attend pediatric services in Primary Care in Catalonia.The measurements will be taken at three points in time, in each of the fathers and/or mothers who respond to a questionnaire regarding their baby's clinical background and characteristics of the baby's exposure, together with variables related to the parents' tobacco consumption. A hair sample of the baby will be taken at the beginning of the study and at six months after the initial visit (biological determination of nicotine). The intervention group will apply a brief intervention in passive smoking after specific training and the control group will apply the habitual care. DISCUSSION: Exposure to ETS is an avoidable factor related to infant morbimortality. Interventions to reduce exposure to ETS in babies are potentially beneficial for their health.The BIBE study evaluates an intervention to reduce exposure to ETS that takes advantage of pediatric visits. Interventions in the form of advice, conducted by pediatric professionals, are an excellent opportunity for prevention and protection of infants against the harmful effects of ETS. TRIAL REGISTRATION: Clinical Trials.gov Identifier: NCT00788996.
Authors: Elena Boldo; Sylvia Medina; Mattias Oberg; Vladimíra Puklová; Odile Mekel; Kristiina Patja; Dafina Dalbokova; Michal Krzyzanowski; Manuel Posada Journal: Public Health Rep Date: 2010 May-Jun Impact factor: 2.792
Authors: Hanns Moshammer; Gerard Hoek; Heike Luttmann-Gibson; Manfred A Neuberger; Temenuga Antova; Ulrike Gehring; Frantiska Hruba; Sam Pattenden; Peter Rudnai; Hana Slachtova; Renata Zlotkowska; Tony Fletcher Journal: Am J Respir Crit Care Med Date: 2006-02-16 Impact factor: 21.405
Authors: R Córdoba-García; N García-Sánchez; R G Suárez López de Vergara; C Galván Fernández Journal: An Pediatr (Barc) Date: 2007-08 Impact factor: 1.500
Authors: Joy M Zakarian; Melbourne F Hovell; Rachel D Sandweiss; C Richard Hofstetter; Georg E Matt; J Thomas Bernert; James Pirkle; S Katharine Hammond Journal: Nicotine Tob Res Date: 2004-12 Impact factor: 4.244
Authors: Laura Díaz-Gete; Elisa Puigdomènech; Elena Mercedes Briones; Mireia Fàbregas-Escurriola; Soraya Fernandez; Jose Luis Del Val; Jose Luis Ballvé; Marc Casajuana; Jessica Sánchez-Fondevila; Lourdes Clemente; Carmen Castaño; Carlos Martín-Cantera Journal: BMC Public Health Date: 2013-04-18 Impact factor: 3.295